Spineguard Cash Flow Conversion Efficiency

Latest as of June 2025: -0.172x

Spineguard cash flow conversion efficiency. Based on the latest financial reports, Spineguard (ALSGD) has a cash flow conversion efficiency ratio of -0.172x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-738.46K ≈ $-863.33K USD) by net assets (€4.28 Million ≈ $5.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Spineguard (2011–2024)

Cash flow conversion efficiency of Spineguard from 2011 to 2024. This chart illustrates how Spineguard's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ALSGD share price today for real-time trading data and today's change.

Spineguard Cash Flow Conversion Ratio Explained

Spineguard cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Spineguard Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spineguard ranked by their cash flow conversion efficiency. Also see market cap of Spineguard for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Esthetics International Group KLSE:5081	0.079x
Zhuhai Sailong Pharmaceutical Co Ltd SHE:002898	-0.076x
Agrimin Ltd AU:AMN	-0.039x
Poxel SA PA:POXEL	-0.124x
RS Public Company Limited BK:RS	-0.029x
Dynaciate Group Bhd KLSE:5178	0.016x
ESSA Pharma Inc NASDAQ:EPIX	-0.039x
Af Legal Group Ltd AU:AFL	-0.015x

Annual Cash Flow Conversion Efficiency for Spineguard (2011–2024)

The table below shows the annual cash flow conversion efficiency of Spineguard from 2011 to 2024. Review ALSGD FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€3.90 Million ≈ $4.56 Million	€-2.35 Million ≈ $-2.74 Million	-0.601x	+0.63%
2023-12-31	€6.03 Million ≈ $7.05 Million	€-3.65 Million ≈ $-4.27 Million	-0.605x	-74.67%
2022-12-31	€5.14 Million ≈ $6.01 Million	€-1.78 Million ≈ $-2.08 Million	-0.346x	-51.31%
2021-12-31	€5.05 Million ≈ $5.90 Million	€-1.16 Million ≈ $-1.35 Million	-0.229x	-100.22%
2020-12-31	€-8.93K ≈ $-10.44K	€-948.67K ≈ $-1.11 Million	106.257x	+27931.10%
2019-12-31	€592.03K ≈ $692.15K	€224.42K ≈ $262.37K	0.379x	-72.27%
2018-12-31	€-489.56K ≈ $-572.35K	€-669.26K ≈ $-782.44K	1.367x	-88.66%
2017-12-31	€-208.50K ≈ $-243.75K	€-2.51 Million ≈ $-2.94 Million	12.051x	+455.49%
2016-12-31	€1.19 Million ≈ $1.39 Million	€-4.03 Million ≈ $-4.72 Million	-3.390x	-518.39%
2015-12-31	€4.73 Million ≈ $5.54 Million	€-2.60 Million ≈ $-3.03 Million	-0.548x	+4.69%
2014-12-31	€5.77 Million ≈ $6.74 Million	€-3.32 Million ≈ $-3.88 Million	-0.575x	-71.23%
2013-12-31	€8.92 Million ≈ $10.42 Million	€-2.99 Million ≈ $-3.50 Million	-0.336x	+39.27%
2012-12-31	€5.32 Million ≈ $6.22 Million	€-2.94 Million ≈ $-3.44 Million	-0.553x	-106.39%
2011-12-31	€7.15 Million ≈ $8.36 Million	€-1.92 Million ≈ $-2.24 Million	-0.268x	--

About Spineguard

PA:ALSGD France Medical Devices

Market Cap

$9.53 Million

€8.15 Million EUR

Market Cap Rank

#27032 Global

#463 in France

Share Price

€0.09

Change (1 day)

-3.02%

52-Week Range

€0.08 - €0.16

All Time High

€5.18